United Kingdom · Question · Written question
UIN 77949
Cerliponase Alfa
Original
Introduced
16 September 2025
Last action
14 October 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
14 October 2025
Summary
To ask the Secretary of State for Health and Social Care, what discussions he has had with the National Institute for Health and Care Excellence on securing long term access to cerliponase alfa.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
16 September 2025
Written question
To ask the Secretary of State for Health and Social Care, what discussions he has had with the National Institute for Health and Care Excellence on securing long term access to cerliponase alfa.
Source: Commons
14 October 2025
Answer
Officials in the Department have had a number of discussions with colleagues in the National Institute for Health and Care Excellence (NICE) about the ongoing appraisal of cerliponase alfa (Brineura) for the treatment of neuronal ceroid lipofuscinosis typ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-09-16/77949
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1836084
- uk · wq-1836084 · source updated 14 October 2025